Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;18(3):262-70.
doi: 10.1016/j.hpb.2015.08.004. Epub 2016 Jan 6.

Perioperative blood transfusion is not associated with overall survival or time to recurrence after resection of perihilar cholangiocarcinoma

Annemiek M Dekker  1 , Jimme K Wiggers  1 , Robert J Coelen  1 , Rowan F van Golen  1 , Marc G H Besselink  1 , Olivier R C Busch  1 , Joanne Verheij  2 , Markus W Hollmann  3 , Thomas M van Gulik  4
Affiliations

Perioperative blood transfusion is not associated with overall survival or time to recurrence after resection of perihilar cholangiocarcinoma

Annemiek M Dekker et al. HPB (Oxford). 2016 Mar.

Abstract

Background: Perioperative blood transfusions have been associated with worse oncological outcome in several types of cancer. The objective of this study was to assess the effect of perioperative blood transfusions on time to recurrence and overall survival (OS) in patients who underwent curative-intent resection of perihilar cholangiocarcinoma (PHC).

Methods: This retrospective cohort study included consecutive patients with resected PHC between 1992 and 2013 in a specialized center. Patients with 90-day mortality after surgery were excluded. Patients who did and did not receive perioperative blood transfusions were compared using univariable Kaplan-Meier analysis and multivariable Cox regression.

Results: Of 145 included patients, 80 (55.2%) received perioperative blood transfusions. The median OS was 49 months for patients without and 41 months for patients with blood transfusions (P = 0.46). In risk-adjusted multivariable Cox regression analysis, blood transfusion was not associated with OS (HR 1.00, 95% CI 0.59-1.68, P = 0.99) or time to recurrence (HR 1.00, 95% CI 0.57-1.78, P = 0.99). In addition, no differences in effect were found between different types of blood products transfused.

Conclusion: Blood transfusion was not associated with survival or time to recurrence after curative resection of PHC in this series. The alleged association is presumably related to the circumstances necessitating blood transfusions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan-Meier curves for overall survival
Figure 2
Figure 2
Kaplan-Meier curves for time to recurrence
See this image and copyright information in PMC

References

    1. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA – Cancer J Clin. 2014;64:9–29. - PubMed
    1. Popescu I., Dumitrascu T. Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg. 2014;399:693–705. - PubMed
    1. D'Angelica M.I., Jarnagin W.R., Blumgart L.H. Resectable hilar cholangiocarcinoma: surgical treatment and long-term outcome. Surg Today. 2004;34:885–890. - PubMed
    1. Carson J.L., Carless P.A., Hebert P.C. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2012;4:CD002042. - PMC - PubMed
    1. Cata J.P., Wang H., Gottumukkala V., Reuben J., Sessler D.I. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth. 2013;110:690–701. - PMC - PubMed

MeSH terms